Clinical Results
ACADIA Pharmaceuticals Presents Positive Top-line Results from Dementia-Related Psychosis Trial
Acadia Pharmaceuticals
PR-M12-19-NI-012Dec 06, 2019
Clinical Trial
Arial Halts Trial for First Drug to Treat DRP Early
Nice Insight
PAO-M09-19-NI-015Sep 20, 2019
Clinical Trials
ACADIA Pharmaceuticals Announces Meets the Primary Phase 3 Endpoint in Patients with Dementia-Related Psychosis
Acadia Pharmaceuticals
PR-M09-19-NI-036Sep 13, 2019
License Agreement
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement for the North American Development and Commercialization of Trofinetide in Rett Syndrome
Acadia Pharmaceuticals
PR-M08-18-NI-071Aug 16, 2018